Research ArticleOriginal Research

The Influence of Dermatologist and Primary Care Physician Visits on Melanoma Outcomes Among Medicare Beneficiaries

Richard G. Roetzheim, Ji-Hyun Lee, Jeanne M. Ferrante, Eduardo C. Gonzalez, Ren Chen, Kate J. Fisher, Kymia Love-Jackson and Ellen P. McCarthy
The Journal of the American Board of Family Medicine November 2013, 26 (6) 637-647; DOI: https://doi.org/10.3122/jabfm.2013.06.130042

References

  1. 1.↵
    1. Siegel R,
    2. Ward E,
    3. Brawley O,
    4. Jemal A
    . Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212–36.
    OpenUrlCrossRefPubMedWeb of Science
  2. 2.↵
    1. Markovic SN,
    2. Erickson LA,
    3. Rao RD,
    4. et al
    . Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment. Mayo Clin Proc 2007;82:490–513.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Epstein D,
    2. Lange J,
    3. Gruber S,
    4. Mofid M,
    5. Koch S
    . Is physician detection associated with thinner melanomas? JAMA 1999;281:640–3.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Kantor J,
    2. Kantor DE
    . Routine dermatologist-performed full-body skin examination and early melanoma detection. Arch Dermatol 2009;145:873–6.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Kovalyshyn I,
    2. Dusza SW,
    3. Siamas K,
    4. Halpern AC,
    5. Argenziano G,
    6. Marghoob AA
    . The impact of physician screening on melanoma detection. Arch Dermatol 2011;147:1269–75.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. McGuire ST,
    2. Secrest AM,
    3. Andrulonis R,
    4. Ferris LK
    . Surveillance of patients for early detection of melanoma: patterns in dermatologist vs patient discovery. Arch Dermatol 2011;147:673–8.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Fisher NM,
    2. Schaffer JV,
    3. Berwick M,
    4. Bolognia JL
    . Breslow depth of cutaneous melanoma: impact of factors related to surveillance of the skin, including prior skin biopsies and family history of melanoma. J Am Acad Dermatol 2005;53:393–406.
    OpenUrlCrossRefPubMedWeb of Science
  8. 8.↵
    1. Durbec F,
    2. Vitry F,
    3. Granel-Brocard F,
    4. et al
    . The role of circumstances of diagnosis and access to dermatological care in early diagnosis of cutaneous melanoma: a population-based study in France. Arch Dermatol 2010;146:240–6.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Eide MJ,
    2. Weinstock MA,
    3. Clark MA
    . The association of physician-specialty density and melanoma prognosis in the United States, 1988 to 1993. J Am Acad Dermatol 2009;60:51–8.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Roetzheim R,
    2. Pal N,
    3. Van Durme D,
    4. et al
    . Increasing supplies of dermatologists and family physicians are associated with earlier stage of melanoma detection. J Am Acad Derm 2000;43:211–8.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    U.S. Preventive Services Task Force. Screening for skin cancer. February 2009. Available from: http://www.uspreventiveservicestaskforce.org/uspstf/uspsskca. htm. Accessed September 12, 2013.
  12. 12.↵
    1. Whitcomb ME,
    2. Cohen JJ
    . The future of primary care medicine. N Engl J Med 2004;351:710–2.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    1. Kimball AB,
    2. Resneck JS Jr.
    . The US dermatology workforce: a specialty remains in shortage. J Am Acad Dermatol 2008;59:741–5.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Uhlenhake E,
    2. Brodell R,
    3. Mostow E
    . The dermatology work force: a focus on urban versus rural wait times. J Am Acad Dermatol 2009;61:17–22.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Tsang MW,
    2. Resneck JS Jr.
    . Even patients with changing moles face long dermatology appointment wait-times: a study of simulated patient calls to dermatologists. J Am Acad Dermatol 2006;55:54–8.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Alam M,
    2. Goldberg LH,
    3. Silapunt S,
    4. et al
    . Delayed treatment and continued growth of nonmelanoma skin cancer. J Am Acad Dermatol 2011;64:839–48.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Ries LAG,
    2. Young JL,
    3. Keel GE,
    4. Eisner MP,
    5. Lin YD,
    6. Horner M-J
    , editors. SEER survival monograph: cancer survival among adults: U.S. SEER Program, 1988–2001, patient and tumor characteristics. NIH pub. no. 07–6215. Bethesda, MD: National Cancer Institute; 2007. Available from: http://seer.cancer. gov/publications/survival/. Accessed September 12, 2013.
  18. 18.↵
    1. Brull R,
    2. Ghali WA,
    3. Quan H
    . Missed opportunities for prevention in general internal medicine. CMAJ 1999;160:1137–40.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Freeman HJ
    . Documentation of rectal examination performance in the clinical teaching unit of a university hospital. Can J Gastroenterol 2000;14:272–6.
    OpenUrlPubMed
  20. 20.↵
    1. Harrison RV,
    2. Janz NK,
    3. Wolfe RA,
    4. Tedeschi PJ,
    5. Huang X,
    6. McMahon LF Jr.
    . 5-Year mammography rates and associated factors for older women. Cancer. 2003;97:1147–55.
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Huth JF,
    2. O'Connor AP
    . Breast cancer screening practices for hospitalized women. J Cancer Educ 1995;10:22–4.
    OpenUrlPubMed
  22. 22.↵
    1. Sharma VK,
    2. Komanduri S,
    3. Nayyar S,
    4. et al
    . An audit of the utility of in-patient fecal occult blood testing. Am J Gastroenterol 2001;96:1256–60.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Trimble CL,
    2. Richards LA,
    3. Wilgus-Wegweiser B,
    4. Plowden K,
    5. Rosenthal DL,
    6. Klassen A
    . Effectiveness of screening for cervical cancer in an inpatient hospital setting. Obstet Gynecol 2004;103:310–6.
    OpenUrlCrossRefPubMed
  24. 24.↵
    1. Van Harrison R,
    2. Janz NK,
    3. Wolfe RA,
    4. et al
    . Characteristics of primary care physicians and their practices associated with mammography rates for older women. Cancer 2003;98:1811–21.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. White MJ
    . Consideration of women's health issues by housestaff performing admitting histories and physical examinations. Acad Med 1993;68:698–700.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Ziffer A,
    2. Song P,
    3. Mandelblatt J
    . Preventive health practices in a teaching hospital: house staff attitudes and performance of gynecological screening. Am J Prev Med 1987;3:142–6.
    OpenUrlPubMed
  27. 27.↵
    1. Yu X,
    2. McBean AM,
    3. Virnig BA
    . Physician visits, patient comorbidities, and mammography use among elderly colorectal cancer survivors. J Cancer Surviv 2007;1:275–82.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Baldwin LM,
    2. Adamache W,
    3. Klabunde CN,
    4. Kenward K,
    5. Dahlman C,
    6. Warren JL
    . Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurement. Med Care 2002;40(8 Suppl):82–95.
    OpenUrl
  29. 29.↵
    1. Valderas JM,
    2. Starfield B,
    3. Forrest CB,
    4. Sibbald B,
    5. Roland M
    . Ambulatory care provided by office-based specialists in the United States. Ann Fam Med 2009;7:104–11.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. Criscione VD,
    2. Weinstock MA
    . Melanoma thickness trends in the United States, 1988–2006. J Invest Dermatol 2010;130:793–7.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Demierre MF,
    2. Chung C,
    3. Miller DR,
    4. Geller AC
    . Early detection of thick melanomas in the United States: beware of the nodular subtype. Arch Dermatol 2005;141:745–50.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Gimotty PA,
    2. Botbyl J,
    3. Soong SJ,
    4. Guerry D
    . A population-based validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol 2005;23:8065–75.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    1. Charlson M,
    2. Pompei P,
    3. Ales K,
    4. Mackenzie C
    . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987;40:373–83.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Klabunde CN,
    2. Potosky AL,
    3. Legler JM,
    4. Warren JL
    . Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000;53:1258–67.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Brookhart MA,
    2. Patrick AR,
    3. Dormuth C,
    4. et al
    . Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol 2007;166:348–54.
    OpenUrlAbstract/FREE Full Text
  36. 36.↵
    1. Ferrante JM,
    2. McCarthy EP,
    3. Gonzalez EC,
    4. et al
    . Primary care utilization and colorectal cancer outcomes among Medicare beneficiaries. Arch Intern Med 2011;171:1747–57.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Lin DY,
    2. Wei LJ,
    3. Ying Z
    . Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 1993; 80:557–72.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Geller AC,
    2. Johnson TM,
    3. Miller DR,
    4. Brooks KR,
    5. Layton CJ,
    6. Swetter SM
    . Factors associated with physician discovery of early melanoma in middle-aged and older men. Arch Dermatol 2009;145:409–14.
    OpenUrlCrossRefPubMed
  39. 39.↵
    1. Di Quinzio ML,
    2. Dewar RA,
    3. Burge FI,
    4. Veugelers PJ
    . Family physician visits and early recognition of melanoma. Can J Public Health 2005;96:136–9.
    OpenUrlPubMedWeb of Science
  40. 40.↵
    1. Chen SC,
    2. Pennie ML,
    3. Kolm P,
    4. et al
    . Diagnosing and managing cutaneous pigmented lesions: primary care physicians versus dermatologists. J Gen Intern Med 2006;21:678–82.
    OpenUrlCrossRefPubMedWeb of Science
  41. 41.↵
    1. Pennie ML,
    2. Soon SL,
    3. Risser JB,
    4. Veledar E,
    5. Culler SD,
    6. Chen SC
    . Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist. Arch Dermatol 2007;143:488–94.
    OpenUrlCrossRefPubMedWeb of Science
  42. 42.↵
    1. Bordeaux JS,
    2. Lu KQ,
    3. Cooper KD
    . Melanoma: prevention and early detection. Semin Oncol 2007;34:460–6.
    OpenUrlPubMed
  43. 43.↵
    1. Goulart JM,
    2. Quigley EA,
    3. Dusza S,
    4. et al
    . Skin cancer education for primary care physicians: a systematic review of published evaluated interventions. J Gen Intern Med 2011;26:1027–35.
    OpenUrlCrossRefPubMed
  44. 44.↵
    1. Wolff T,
    2. Tai E,
    3. Miller T
    . Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2009;150:194–8.
    OpenUrlPubMed
  45. 45.↵
    1. Welch HG,
    2. Woloshin S,
    3. Schwartz LM
    . Skin biopsy rates and incidence of melanoma: population based ecological study. BMJ 2005;331:481.
    OpenUrlAbstract/FREE Full Text
  46. 46.↵
    1. Welch HG,
    2. Black WC
    . Overdiagnosis in cancer. J Natl Cancer Inst 2010;102:605–13.
    OpenUrlAbstract/FREE Full Text
  47. 47.↵
    1. Jemal A,
    2. Saraiya M,
    3. Patel P,
    4. et al
    . Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992–2006. J Am Acad Dermatol 2011;65(5 Suppl 1):S17–25.e1–3.
    OpenUrlCrossRefPubMed
  48. 48.↵
    1. McLaughlin JM,
    2. Fisher JL,
    3. Paskett ED
    . Marital status and stage at diagnosis of cutaneous melanoma: results from the Surveillance Epidemiology and End Results (SEER) program, 1973–2006. Cancer 2011;117:1984–93.
    OpenUrlCrossRefPubMed
  49. 49.↵
    1. Reyes Ortiz CA,
    2. Freeman JL,
    3. Kuo YF,
    4. Goodwin JS
    . The influence of marital status on stage at diagnosis and survival of older persons with melanoma. J Gerontol A Biol Sci Med Sci 2007;62:892–8.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    1. Baumert J,
    2. Plewig G,
    3. Volkenandt M,
    4. Schmid-Wendtner MH
    . Factors associated with a high tumour thickness in patients with melanoma. Br J Dermatol 2007;156:938–44.
    OpenUrlCrossRefPubMedWeb of Science
  51. 51.↵
    1. Mandala M,
    2. Imberti GL,
    3. Piazzalunga D,
    4. et al
    . Association of socioeconomic status with Breslow thickness and disease-free and overall survival in stage I-II primary cutaneous melanoma. Mayo Clin Proc 2011;86:113–9.
    OpenUrlCrossRefPubMed
  52. 52.↵
    1. Swetter SM,
    2. Johnson TM,
    3. Miller DR,
    4. Layton CJ,
    5. Brooks KR,
    6. Geller AC
    . Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness. Arch Dermatol 2009;145:397–404.
    OpenUrlCrossRefPubMed
  53. 53.↵
    1. Ward EM,
    2. Fedewa SA,
    3. Cokkinides V,
    4. Virgo K
    . The association of insurance and stage at diagnosis among patients aged 55 to 74 years in the national cancer database. Cancer J 2010;16:614–21.
    OpenUrlCrossRefPubMedWeb of Science
  54. 54.↵
    1. Roetzheim RG,
    2. Pal N,
    3. Tennant C,
    4. et al
    . Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 1999;91:1409–15.
    OpenUrlAbstract/FREE Full Text
  55. 55.↵
    1. Watson M,
    2. Johnson CJ,
    3. Chen VW,
    4. et al
    . Melanoma surveillance in the United States: overview of methods. J Am Acad Dermatol 2011;65:S6–16.
    OpenUrlCrossRefPubMed
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords